Form 13-F position report

BIOGEN INC

Reported by MORGAN STANLEY

BIIB CUSIP 09062X103 Manager CIK 0000895421

Reported 1,782,356 shares, down 104,890 (5.6%) from the prior quarter.

Reported value -25.5%; share count -5.6% vs. the prior quarter.

Reduced
% of reported 13F value 0.02% This manager · Q4 2024
Shares 1,782,356 Quarter-end amount reported
Reported value $272,558,304 Fair value at quarter end
Consecutive quarters held 47 Through Q4 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 213294000
2021-12-31 187253000
2022-03-31 201297000
2022-06-30 280813000
2022-09-30 331829000
2022-12-31 394006366
2023-03-31 363066271
2023-06-30 407705928
2023-09-30 383745281
2023-12-31 408281862
2024-03-31 366869843
2024-06-30 372421216
2024-09-30 365824336
2024-12-31 272558304
2025-03-31 272403521
2025-06-30 245680815
2025-09-30 315395300
2025-12-31 409179635
2026-03-31 397998875
2026-06-30 520979947

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for BIOGEN INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 2,411,271 +240,331 (11.1%) 0.03% $520,979,947 2026-08-13
Q1 2026 Reduced 2,170,940 -154,073 (-6.6%) 0.02% $397,998,875 2026-05-15
Q4 2025 Added 2,325,013 +73,478 (3.3%) 0.02% $409,179,635 2026-02-13
Q3 2025 Added 2,251,535 +295,325 (15.1%) 0.02% $315,395,300 2025-11-14
Q2 2025 Reduced 1,956,210 -34,458 (-1.7%) 0.02% $245,680,815 2025-08-15
Q1 2025 Added 1,990,668 +208,312 (11.7%) 0.02% $272,403,521 2025-05-15
Q4 2024 Reduced 1,782,356 -104,890 (-5.6%) 0.02% $272,558,304 2025-02-14
Q3 2024 Added 1,887,246 +280,738 (17.5%) 0.03% $365,824,336 2024-11-14
Q2 2024 Reduced 1,606,508 -94,875 (-5.6%) 0.03% $372,421,216 2024-08-14
Q1 2024 Added 1,701,383 +123,606 (7.8%) 0.03% $366,869,843 2024-05-15
Q4 2023 Added 1,577,777 +84,664 (5.7%) 0.04% $408,281,862 2024-02-13
Q3 2023 Added 1,493,113 +61,814 (4.3%) 0.04% $383,745,281 2023-11-15
Q2 2023 Added 1,431,299 +125,448 (9.6%) 0.04% $407,705,928 2023-08-14
Q1 2023 Reduced 1,305,851 -116,965 (-8.2%) 0.04% $363,066,271 2023-05-15
Q4 2022 Added 1,422,816 +180,012 (14.5%) 0.04% $394,006,366 2023-02-14
Q3 2022 Reduced 1,242,804 -134,131 (-9.7%) 0.05% $331,829,000 2022-11-14
Q2 2022 Added 1,376,935 +421,110 (44.1%) 0.04% $280,813,000 2022-08-15
Q1 2022 Added 955,825 +175,345 (22.5%) 0.03% $201,297,000 2022-05-13
Q4 2021 Added 780,480 +26,765 (3.6%) 0.02% $187,253,000 2022-02-14
Q3 2021 Added 753,715 +51,540 (7.3%) 0.03% $213,294,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1044 managers reported BIOGEN INC for Q4 2024.

Managers reporting BIOGEN INC in Q4 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 16,748,875 +70,368 0.04% $2,561,237,965 47 qtrs
PRIMECAP MANAGEMENT CO CA Reduced 16,046,209 -268,870 1.9% $2,453,786,283 47 qtrs
BlackRock Inc Added 15,473,710 +126,669 0.05% $2,366,239,663 2 qtrs
STATE STREET CORPORATION Added 7,398,248 +53,288 0.04% $1,131,229,765 47 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 4,930,723 -200,470 0.14% $754,006,161 47 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 3,695,476 +82,456 0.04% $563,708,972 47 qtrs
T Rowe Price Investment Management Inc Reduced 3,099,786 -1,156,500 0.29% $474,020,000 7 qtrs
Pacer Advisors Inc Added 2,667,531 +2,648,024 0.88% $407,918,840 37 qtrs
NORGES BANK Added 2,325,199 +60,807 0.05% $355,569,431 47 qtrs
Invesco Ltd Added 2,128,807 +499,074 0.06% $325,537,166 47 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2024
Filed
February 14, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,405,343
Shared
0
None
377,013

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.